RTS is subdivided into type 1 and type 2 associated with pathogenic variants or re-arrangements in the CREBBPand EP300genes respectively.
Pathogenic variants in CREBBPand EP300have been identified in respectively 55-75% and 8-11% of clinically RTS diagnosed cases.
EP300